BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prozac
,
rs3825942
,
PPARA
,
G-protein-coupled receptor binding
,
Inflammatory disorder
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cyclin dependent kinase 9
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
T cell acute lymphoblastic leukemia MOLT4 cells treated with cyclin-dependent kinase inhibitors
NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
Breast cancer MCF-7 cells with Abemaciclib and SR11302
Acute monocytic leukemia cell line THP1 with PAF1 shRNA knockdown
Melanoma SK-MEL-5 cells treated with Palbociclib
Explore Curated Studies Results
Literature
Most Relevant Literature
Cyclin-dependent kinase 9 activity regulates neutrophil spontaneous apoptosis.
Comparative structural and functional studies of 4-(thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbon…
Recruitment of cyclin-dependent kinase 9 to nuclear compartments during cytomegalovirus late replica…
Flavopiridol protects against inflammation by attenuating leukocyte-endothelial interaction via inhi…
Cyclin-dependent kinase 7/9 inhibitor SNS-032 abrogates FIP1-like-1 platelet-derived growth factor r…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Adva…
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder
A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS
Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ